Fund Holdings — Vivo Capital, LLC

Total Portfolio Value:
$1.27B
Total Bought:
$212.03M
Total Sold:
$245.06M
Net Transaction:
-$33.03M
Notable People:
Edgar George Engleman, Frank Fang-Chien Kung, Shan (Nmn) Fu, Michael J. Chang, Gaurav Aggarwal
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Soleno Therapeutics Inc8,418,0938,418,0930$338.83M$360.29M28.31%+$21.47M
Geron Corporation(GERN)24,143,68127,225,292+3,081,611$50.94M$89.84M7.06%+$38.90M
Harmony Biosciences Holdings, Inc.(HRMY)2,606,2472,606,2470$84.18M$87.52M6.88%+$3.34M
Sinovac Biotech, Ltd.SHS(SVA)011,800,000+11,800,000$0$76.35M6.00%+$76.35M
Avadel Pharmaceuticals PLCADR4,096,4283,972,099-124,329$57.84M$67.09M5.27%+$9.25M
Verona Pharma PLCADS4,249,9183,610,177-639,741$84.49M$58.09M4.56%-$26.40M
ALX Oncology Holdings Inc.(ALXO)4,220,0484,220,0480$62.84M$47.05M3.70%-$15.78M
Dyne Therapeutics, Inc.(DYN)1,035,1361,635,136+600,000$13.77M$46.42M3.65%+$32.65M
Terns Pharmaceuticals Inc6,657,9926,657,9920$43.21M$43.68M3.43%+$466.1K
Astria Therapeutics Inc2,482,7272,329,027-153,700$19.07M$32.78M2.58%+$13.71M
Viridian Therapeutics, Inc.(VRDN)1,678,2071,678,2070$36.55M$29.39M2.31%-$7.17M
Silence Therapeutics plcADS(SLN)510,2041,105,454+595,250$8.86M$23.88M1.88%+$15.02M
Olema Pharmaceuticals, Inc.(OLMA)1,873,7041,873,7040$26.29M$21.21M1.67%-$5.08M
Adverum Biotechnologies, Inc.01,500,000+1,500,000$0$21.21M1.67%+$21.21M
Alpine Immune Sciences Inc819,275520,505-298,770$15.62M$20.79M1.63%+$5.18M
Tarsus Pharmaceuticals, Inc.(TARS)1,784,006565,550-1,218,456$36.13M$20.56M1.62%-$15.57M
Verastem, Inc.(VSTM)1,538,4611,538,4610$12.52M$18.15M1.43%+$5.63M
Crinetics Pharmaceuticals Inc350,000350,0000$12.45M$16.38M1.29%+$3.93M
Cogent Biosciences, Inc.(COGT)2,244,9412,244,9410$13.20M$15.09M1.19%+$1.89M
Sera Prognostics, Inc.(SERA)1,650,4401,650,4400$9.87M$15.02M1.18%+$5.15M
Regulus Therapeutics Inc05,000,000+5,000,000$0$14.40M1.13%+$14.40M
Tourmaline Bio Inc.591,882591,8820$15.50M$13.55M1.07%-$1.94M
COMPASS Pathways plcADS(CMPS)1,608,0001,608,0000$14.07M$13.38M1.05%-$691.4K
ORIC Pharmaceuticals, Inc.(ORIC)849,681849,6810$7.82M$11.68M0.92%+$3.87M
Engene Holdings Inc.
COM
678,705678,7050$6.26M$11.50M0.90%+$5.24M
Genetron Holdings LtdADS2,708,0562,708,0560$9.97M$10.90M0.86%+$934.3K
IO Biotech Inc6,173,4396,173,4390$11.61M$10.68M0.84%-$926.0K
Savara Inc.(SVRA)2,088,3232,088,3230$9.82M$10.40M0.82%+$584.7K
Zai Lab LimitedADR(ZLAB)411,677531,198+119,521$11.25M$8.51M0.67%-$2.74M
Delcath Systems, Inc.(DCTH)855,1911,666,746+811,555$3.56M$7.95M0.62%+$4.39M
Rezolute, Inc.(RZLT)3,242,8422,797,704-445,138$3.22M$7.13M0.56%+$3.92M
Compass Therapeutics, Inc.(CMPX)3,556,0233,556,0230$5.55M$7.04M0.55%+$1.49M
Instil Bio, Inc.(TIL)624,340624,338-2$4.76M$6.74M0.53%+$1.99M
Q32 Bio Inc.(QTTB)0370,068+370,068$0$6.31M0.50%+$6.31M
Bolt Therapeutics Inc3,521,2913,521,2910$3.94M$4.93M0.39%+$986.0K
Unicycive Therapeutics3,470,1523,470,1520$3.01M$4.79M0.38%+$1.78M
Allakos Inc2,988,0002,988,0000$8.16M$3.76M0.30%-$4.39M
Aligos Therapeutics Inc3,547,0303,547,0300$2.36M$3.48M0.27%+$1.12M
DBV Technologies SAADS2,708,8752,708,8750$2.58M$2.03M0.16%-$551.8K
Codexis, Inc.(CDXS)388,144388,1440$1.18M$1.35M0.11%+$170.8K
Whitehawk Therapeutics, Inc.(WHWK)509,572509,5720$1.03M$1.19M0.09%+$163.1K
Precision BioSciences, Inc.(DTIL)04,675+4,675$0$63.4K0.00%+$63.4K
Apogee Therapeutics Inc400,0000-400,000$11.18M$0—-$11.18M
Arrowhead Pharmaceuticals, Inc.(ARWR)137,4110-137,411$4.20M$0—-$4.20M
Gracell Biotechnologies IncADS9,546,4850-9,546,485$95.85M$0—-$95.85M
Homology Medicines, Inc.370,0680-370,068$225.0K$0—-$225.0K
Icosavax, Inc.1,704,5680-1,704,568$26.86M$0—-$26.86M
Iovance Biotherapeutics, Inc.(IOVA)655,0570-655,057$5.33M$0—-$5.33M
KalVista Pharmaceuticals Inc.856,0080-856,008$10.49M$0—-$10.49M
Pharvaris NV
COM
285,0000-285,000$7.99M$0—-$7.99M
Precision BioSciences, Inc.(DTIL)140,2550-140,255$51.2K$0—-$51.2K
Rayzebio Inc110,5810-110,581$6.87M$0—-$6.87M
Page 1 of 1
Vivo Capital, LLC — 13F Holdings — Q1 2024 | TickerTrail